Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
This 10mg lyophilised formulation is supplied at 99% purity and intended strictly for laboratory research purposes
Established Manufacturer: Professional manufacturer established in 2001, specializing in veterinary drugs
The synergistic insulin secretion produced by simultaneous GIP and GLP-1 receptor activation is mechanistically distinct from what amylin/GLP-1 combinations provide, and the SURPASS trial data in diabetic populations is among the strongest in the field
The four categories where BPC-157 consistently delivers at our clinic are gut lining repair, tendon and ligament recovery, joint inflammation support, and systemic tissue repair after injury or surgery
